GlassScriptPhysician profile
Mauro B Ruffy
NPI 1376725630
$4,278.78
in general payments reported to CMS, 2019-2025
12 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $87.41 · 2021: $1,900 · 2022: $513 · 2023: $214 · 2024: $346 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $941.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $941.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,860.10 | 2020-2025 | |
| Stryker Corporation | $1,356.63 | 2019-2024 | Scopis Ent, Clarifix Cryotherapy Device, Latera |
| Medtronic, INC. | $268.39 | 2021-2025 | Rapidvac |
| Optinose US, INC. | $266.62 | 2019-2023 | |
| Spirair, INC. | $186.47 | 2025 | |
| Baxter Healthcare | $95.43 | 2019 | |
| Exact Sciences Corporation | $68.43 | 2023-2024 | Cologuard Collection Kit |
| Ethicon US, LLC | $44.81 | 2025 | Monocryl |
| Medtronic USA, INC. | $41.85 | 2019 | |
| Smith+Nephew, INC. | $32.85 | 2025 | Tula |
| Integra Lifesciences Corporation | $31.82 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Intersect Ent, INC. | $25.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$240,157.10 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauro Ruffy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.